# A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

> **NCT06742853** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 81 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** AZD0780
- **DRUG:** Ezetimibe
- **DRUG:** Rosuvastatin
- **DRUG:** Bempedoic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06742853
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-20
- **Primary completion:** 2025-10-29
- **Final completion:** 2025-10-29
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06742853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06742853, "A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06742853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*